Merck will spend about $11.5 billion to acquire Acceleron Pharma and its treatment for high pressure in vessels that carry blood to the lungs …
Merck will spend about $11.5 billion to acquire Acceleron Pharma and its treatment for high pressure in vessels that carry blood to the lungs from the heart.
